Protara Therapeutics, Inc. (TARA) Tops Q3 EPS by 7c
Tweet
Share
E-mailGet Alerts TARA Hot Sheet
Join SI Premium – FREE
Protara Therapeutics, Inc. (NASDAQ: TARA) reported Q3 EPS of ($0.31), $0.07 better than the analyst estimate of ($0.38).
For earnings history and earnings-related data on Protara Therapeutics, Inc. (TARA) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Toll Brothers (TOL) Tops Q3 EPS by 5c, reaffirms guidance
- Jack Henry (JKHY) Tops Q4 EPS by 13c
- CLSA Starts Beike (BEKE) at Outperform (2)
Create E-mail Alert Related Categories
EarningsRelated Entities
Earnings, Maynard Um, Mark Zuckerberg, ARKSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
